bi 655064
mAbexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01510782)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 655064
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03385564 | Phase 2 | Jan 9, 2018 | Boehringer Ingelheim |
| NCT02770170 | Phase 2 | May 16, 2016 | Boehringer Ingelheim |
| NCT02331277 | Phase 1 | Sep 1, 2015 | Boehringer Ingelheim |
| NCT02009761 | Phase 1 | Dec 1, 2013 | Boehringer Ingelheim |
| NCT01917916 | Phase 1 | Aug 1, 2013 | Boehringer Ingelheim |
| NCT01751776 | Phase 1 | Dec 1, 2012 | Boehringer Ingelheim |
| NCT01510782 | Phase 1 | Jan 1, 2012 | Boehringer Ingelheim |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 7 | 7 | 2 | 2012 |
1 organizations
Page 1 / 1